Start-up factory
TECHNO / PRODUITS
Two active ingredients are in development to regulate hyperglycemia, which is a major risk factor for type 2 diabetes.
PRODUCTS PORTFOLIO
APPLICATIONS
This non-pharmacological treatment has been developed for preventive medicine. It enables prediabetics to regulate their postprandial hyperglycemia and thus restore normal blood sugar levels to prevent the development of type 2 diabetes.
ADVANTAGES
The treatment with Ora1, has a rapid and direct effect on insulin secretion. Weight loss is not necessary to measure its effectiveness.
